The Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) funding program from the National Institutes of Health (NIH) supports research in
- discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to psychiatric disorders; and
- to generate new insight into the biology of relevant diseases and processes that have yet to be validated as important drug targets.
